Matthew A Clarke

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Top Venues

Nature reviews. Cancer

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Nature communications

University College London

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Apr 01 2020

United Kingdom

Research Fellow :: Cancer Institute

University of Cambridge Oct 01 2018 - Mar 31 2020

United Kingdom

Post-Doctoral Research Associate :: Department of Biochemistry

Education History

University of Cambridge Oct 01 2013 - Nov 24 2018

United Kingdom

PHD :: Department of Biochemistry

University of Cambridge Oct 01 2012

United Kingdom

MSC

University of Cambridge Oct 01 2009

United Kingdom

MSC

Publications

Rowan S M Howell, James Davies, Matthew A Clarke, Anna Appios, Inês Mesquita, Yashoda Jayal, Benjamin Ringham-Terry, Isabel Boned Del Rio, Jasmin Fisher, Clare L Bennett
Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling. Science advances 9 (15) (2023)
Laure Talarmain, Matthew A Clarke, David Shorthouse, Lilia Cabrera-Cosme, David G Kent, Jasmin Fisher, Michael W J Hall
HOXA9 has the hallmarks of a biological switch with implications in blood cancers. Nature communications 13 (1) (2022)
Matthew A Clarke, Jasmin Fisher
Executable cancer models: successes and challenges. Nature reviews. Cancer 20 (6) (2020)
Peter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, Catherine H Wilson, Roderik M Kortlever, Nir Piterman, Trevor Littlewood, Gerard I Evan, Jasmin Fisher
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling. Proceedings of the National Academy of Sciences of the United States of America 116 (44) (2019)